Advanced Pharmaceutical Bulletin (Jan 2022)

Medicinal Plants with Potential Inhibitory Bioactive Compounds against Coronaviruses

  • Olutayo Ademola Adeleye,
  • Oluyemisi Adebowale Bamiro,
  • Lateef Gbenga Bakre,
  • Florence Olubola Odeleye,
  • Modupe Nofisat Adebowale,
  • Olufemi Lionel Okunye,
  • Mariam Adeola Sodeinde,
  • Adannaya Charity Adebona,
  • Farid Menaa

DOI
https://doi.org/10.34172/apb.2022.003
Journal volume & issue
Vol. 12, no. 1
pp. 7 – 16

Abstract

Read online

Medicinal plant is a major source of drug discovery for disease management. Over 85% of the population in Asia and in the Middle East use herbal medicine for disease management such as SARS caused by coronavirus. Infection from coronavirus is initiated by entry of the virus into a susceptible host cell. The two human coronaviruses of public health importance two decades ago were SARS-CoV and MERS-CoV and now SARS-CoV 2. These three viruses belong to the same class of beta coronavirus and are somewhat similar in genome sequencing, life cycle, mode of entry into a host, mode of transmission and clinical manifestations. This review identified twenty medicinal plants with potential inhibitory bioactive compounds from natural sources that are active against coronaviruses that could be developed into various drug delivery systems. It also highlighted several evidences to show that medicinal plant used in the treatment of SARS-CoV may offer some sort of relief from the burden of COVID 19 pandemic. Since there is no specific treatment for COVID 19 yet, the search for medicinal plants with inhibitory bioactive compounds against coronavirus could be the long awaited breakthrough scientists have been searching to change the narratives of Covid-19 pandemic.

Keywords